New robot could transform hysterectomy surgery

NCT ID NCT07120945

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new robotic system, the Medtronic Hugo™, for performing hysterectomies. It includes 70 patients with conditions like uterine fibroids, endometriosis, or certain cancers. The goal is to see if the robot is safe and can complete the surgery without switching to other methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Medtronic Hugo™ Robotic-Assisted Surgery (RAS) system
What this could lead to
If successful, this could provide a new robotic option for hysterectomy, potentially improving surgical precision and recovery.
What could go wrong
This is an early-stage, single-arm study with only 70 participants, so results may not apply broadly. There are standard surgical risks like infection or complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOMYOSIS OF UTERUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Allegheny Health Network - West Penn

    Pittsburgh, Pennsylvania, 15224, United States

  • Ascension St. Vincent's Riverside

    Jacksonville, Florida, 32204, United States

  • Duke University

    Durham, North Carolina, 27710, United States

  • Swedish Medical Center

    Seattle, Washington, 98104, United States

  • The University of South Florida

    Tampa, Florida, 33606, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.